Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 2 (Literature review)
In the second part of the review, we continue the discussion of biomarkers that have a diagnostic and prognostic significance in acute myocardial infarction (AMI). The study of the AMI pathophysiology through the experimental and clinical research contributes to the discovery of new regulatory molec...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Eco-vector
2020-12-01
|
| Series: | Клиническая практика |
| Subjects: | |
| Online Access: | https://journals.eco-vector.com/clinpractice/article/viewFile/48893/pdf |
| _version_ | 1797724272316121088 |
|---|---|
| author | Aleksey M. Chaulin Dmitry V. Duplyakov |
| author_facet | Aleksey M. Chaulin Dmitry V. Duplyakov |
| author_sort | Aleksey M. Chaulin |
| collection | DOAJ |
| description | In the second part of the review, we continue the discussion of biomarkers that have a diagnostic and prognostic significance in acute myocardial infarction (AMI). The study of the AMI pathophysiology through the experimental and clinical research contributes to the discovery of new regulatory molecules and pathogenetic mechanisms underlying AMI. At the same time, many molecules involved in the pathogenesis of AMI can be used as effective biomarkers for the diagnosis and prediction of AMI. This article discusses in detail the diagnostic and prognostic value of inflammatory biomarkers of AMI (C-reactive protein, interleukin-6, tumor necrosis factor-alpha, myeloperoxidase, matrix metalloproteinases, soluble form of CD40 ligand, procalcitonin, placental growth factor) and a number of recently discovered new biomarkers of AMI (microribonucleic acids, galectin-3, stimulating growth factor expressed by gene 2, growth differentiation factor 15, proprotein convertase of subtilisin-kexin type 9). |
| first_indexed | 2024-03-12T10:14:00Z |
| format | Article |
| id | doaj.art-9caeff6ac12d403cb95833fecf8d0953 |
| institution | Directory Open Access Journal |
| issn | 2220-3095 2618-8627 |
| language | English |
| last_indexed | 2024-03-12T10:14:00Z |
| publishDate | 2020-12-01 |
| publisher | Eco-vector |
| record_format | Article |
| series | Клиническая практика |
| spelling | doaj.art-9caeff6ac12d403cb95833fecf8d09532023-09-02T10:37:16ZengEco-vectorКлиническая практика2220-30952618-86272020-12-01114708210.17816/clinpract4889353294Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 2 (Literature review)Aleksey M. Chaulin0https://orcid.org/0000-0002-2712-0227Dmitry V. Duplyakov1https://orcid.org/0000-0002-6453-2976Samara Regional Cardiology DispensarySamara Regional Cardiology DispensaryIn the second part of the review, we continue the discussion of biomarkers that have a diagnostic and prognostic significance in acute myocardial infarction (AMI). The study of the AMI pathophysiology through the experimental and clinical research contributes to the discovery of new regulatory molecules and pathogenetic mechanisms underlying AMI. At the same time, many molecules involved in the pathogenesis of AMI can be used as effective biomarkers for the diagnosis and prediction of AMI. This article discusses in detail the diagnostic and prognostic value of inflammatory biomarkers of AMI (C-reactive protein, interleukin-6, tumor necrosis factor-alpha, myeloperoxidase, matrix metalloproteinases, soluble form of CD40 ligand, procalcitonin, placental growth factor) and a number of recently discovered new biomarkers of AMI (microribonucleic acids, galectin-3, stimulating growth factor expressed by gene 2, growth differentiation factor 15, proprotein convertase of subtilisin-kexin type 9).https://journals.eco-vector.com/clinpractice/article/viewFile/48893/pdflaboratory diagnosticsacute myocardial infarctionamibiomarkersc-reactive proteininterleukin-6tumor necrosis factor-alphamyeloperoxidasematrix metalloproteinasesprocalcitoninmicroribonucleic acidsgalectin-3proprotein convertase subtilisin-kexin type 9 |
| spellingShingle | Aleksey M. Chaulin Dmitry V. Duplyakov Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 2 (Literature review) Клиническая практика laboratory diagnostics acute myocardial infarction ami biomarkers c-reactive protein interleukin-6 tumor necrosis factor-alpha myeloperoxidase matrix metalloproteinases procalcitonin microribonucleic acids galectin-3 proprotein convertase subtilisin-kexin type 9 |
| title | Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 2 (Literature review) |
| title_full | Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 2 (Literature review) |
| title_fullStr | Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 2 (Literature review) |
| title_full_unstemmed | Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 2 (Literature review) |
| title_short | Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 2 (Literature review) |
| title_sort | biomarkers of acute myocardial infarction diagnostic and prognostic value part 2 literature review |
| topic | laboratory diagnostics acute myocardial infarction ami biomarkers c-reactive protein interleukin-6 tumor necrosis factor-alpha myeloperoxidase matrix metalloproteinases procalcitonin microribonucleic acids galectin-3 proprotein convertase subtilisin-kexin type 9 |
| url | https://journals.eco-vector.com/clinpractice/article/viewFile/48893/pdf |
| work_keys_str_mv | AT alekseymchaulin biomarkersofacutemyocardialinfarctiondiagnosticandprognosticvaluepart2literaturereview AT dmitryvduplyakov biomarkersofacutemyocardialinfarctiondiagnosticandprognosticvaluepart2literaturereview |